Association Between Cardiac Radiation Exposure and the Risk of Arrhythmia in Breast Cancer Patients Treated With Radiotherapy: A Case-Control Study.

breast cancer cardiac arrhythmia cardiac dosimetry cardiotoxicity radiation therapy

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 09 03 2022
accepted: 02 06 2022
entrez: 21 7 2022
pubmed: 22 7 2022
medline: 22 7 2022
Statut: epublish

Résumé

Previous studies suggested that radiation therapy (RT) for breast cancer (BC) can induce cardiac arrhythmias and conduction disorders. However, the association with mean heart dose and specific cardiac substructures doses was less studied. We conducted a nested case-control study based on French BC patients, enrolled in the European MEDIRAD-BRACE study (https://clinicaltrials.gov, Identifier: NCT03211442), who underwent three-dimensional conformal radiation therapy (3D-CRT) between 2009 and 2013 and were retrospectively followed until 2019. Cases were incident cases of cardiac arrhythmia. Controls without arrhythmia were selected with propensity-scored matching by age, duration of follow-up, chemotherapy, hypertension, and diabetes (ratio 1:4 or 5). Doses to the whole heart (WH), left and right atria (LA and RA), and left and right ventricles (LV and RV) were obtained after delineation with multi-atlas-based automatic segmentation. The study included 116 patients (21 cases and 95 controls). Mean age at RT was 64 ± 10 years, mean follow-up was 7.0 ± 1.3 years, and mean interval from RT to arrhythmia was 4.3 ± 2.1 years. None of the results on association between arrhythmia and cardiac doses reached statistical significance. However, the proportion of right-sided BC was higher among patients with arrhythmia than among controls (57% vs. 51%, OR = 1.18, Despite non-significant results, our exploratory investigation on BC patients treated with RT is the first study to suggest that right-sided BC patients and the right atrium irradiation may require special attention regarding the risk of cardiac arrhythmia and conduction disorders. Further studies are needed to expand on this topic.

Sections du résumé

Background UNASSIGNED
Previous studies suggested that radiation therapy (RT) for breast cancer (BC) can induce cardiac arrhythmias and conduction disorders. However, the association with mean heart dose and specific cardiac substructures doses was less studied.
Materials and Methods UNASSIGNED
We conducted a nested case-control study based on French BC patients, enrolled in the European MEDIRAD-BRACE study (https://clinicaltrials.gov, Identifier: NCT03211442), who underwent three-dimensional conformal radiation therapy (3D-CRT) between 2009 and 2013 and were retrospectively followed until 2019. Cases were incident cases of cardiac arrhythmia. Controls without arrhythmia were selected with propensity-scored matching by age, duration of follow-up, chemotherapy, hypertension, and diabetes (ratio 1:4 or 5). Doses to the whole heart (WH), left and right atria (LA and RA), and left and right ventricles (LV and RV) were obtained after delineation with multi-atlas-based automatic segmentation.
Results UNASSIGNED
The study included 116 patients (21 cases and 95 controls). Mean age at RT was 64 ± 10 years, mean follow-up was 7.0 ± 1.3 years, and mean interval from RT to arrhythmia was 4.3 ± 2.1 years. None of the results on association between arrhythmia and cardiac doses reached statistical significance. However, the proportion of right-sided BC was higher among patients with arrhythmia than among controls (57% vs. 51%, OR = 1.18,
Conclusion UNASSIGNED
Despite non-significant results, our exploratory investigation on BC patients treated with RT is the first study to suggest that right-sided BC patients and the right atrium irradiation may require special attention regarding the risk of cardiac arrhythmia and conduction disorders. Further studies are needed to expand on this topic.

Identifiants

pubmed: 35860581
doi: 10.3389/fonc.2022.892882
pmc: PMC9289188
doi:

Banques de données

ClinicalTrials.gov
['NCT03211442']

Types de publication

Journal Article

Langues

eng

Pagination

892882

Informations de copyright

Copyright © 2022 Errahmani, Locquet, Spoor, Jimenez, Camilleri, Bernier, Broggio, Monceau, Ferrières, Thariat, Boveda, Kirova, Loap, Langendijk, Crijns and Jacob.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer MB is currently organizing a Research Topic with the author VM.

Références

JACC CardioOncol. 2021 Sep 21;3(3):343-359
pubmed: 34604796
Lancet. 2011 Nov 12;378(9804):1707-16
pubmed: 22019144
Radiat Oncol. 2019 Feb 7;14(1):29
pubmed: 30732640
Int J Cardiol. 1993 May;39(2):151-6
pubmed: 8314649
J Am Coll Cardiol. 2017 Nov 14;70(20):2552-2565
pubmed: 29145955
Acta Oncol. 2022 Apr;61(4):496-499
pubmed: 35012415
Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1444-51
pubmed: 20605341
Cancer Radiother. 2021 Feb;25(1):13-20
pubmed: 33288407
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):541-548
pubmed: 29280448
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
J Cardiol. 2016 Jun;67(6):567-71
pubmed: 26359709
Radiat Oncol. 2019 Nov 14;14(1):204
pubmed: 31727075
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
Pract Radiat Oncol. 2021 Jul-Aug;11(4):e434-e437
pubmed: 33561549
Radiother Oncol. 2017 Nov;125(2):293-300
pubmed: 29050957
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S77-85
pubmed: 20171522
J Clin Oncol. 2007 Jul 20;25(21):3031-7
pubmed: 17634481
Radiother Oncol. 2021 Oct;163:46-54
pubmed: 34343547
Int J Cardiol. 2016 Jan 1;202:5-6
pubmed: 26368026
J Clin Oncol. 2017 May 20;35(15):1641-1649
pubmed: 28319436
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Cancer Radiother. 2022 Feb 25;:
pubmed: 35227593
Lancet. 2005 Dec 17;366(9503):2087-106
pubmed: 16360786
Pacing Clin Electrophysiol. 1991 Jul;14(7):1112-8
pubmed: 1715548
Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):386-387
pubmed: 32386738
J Clin Oncol. 2012 Feb 1;30(4):380-6
pubmed: 22203772
Cardiovasc Res. 2019 Apr 15;115(5):878-894
pubmed: 30698686
Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):10-8
pubmed: 20421148
J Clin Oncol. 2017 Apr 10;35(11):1171-1178
pubmed: 28095159
Int J Cardiol Heart Vasc. 2021 Dec 25;38:100936
pubmed: 35005214
Radiother Oncol. 2011 Aug;100(2):167-75
pubmed: 21752480

Auteurs

Mohamed Yassir Errahmani (MY)

Laboratory of Epidemiology, Institute for Radiation Protection and Nuclear Safety (IRSN), Fontenay-Aux-Roses, France.
University Paris-Saclay, Gif-sur-Yvette, France.

Médéa Locquet (M)

Laboratory of Epidemiology, Institute for Radiation Protection and Nuclear Safety (IRSN), Fontenay-Aux-Roses, France.

Daan Spoor (D)

Department of Radiation Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, Netherlands.

Gaelle Jimenez (G)

Department of Radiation Oncology (Oncorad), Clinique Pasteur, Toulouse, France.

Jérémy Camilleri (J)

Department of Radiation Oncology (Oncorad), Clinique Pasteur, Toulouse, France.

Marie-Odile Bernier (MO)

Laboratory of Epidemiology, Institute for Radiation Protection and Nuclear Safety (IRSN), Fontenay-Aux-Roses, France.

David Broggio (D)

Department of Dosimetry, Institute for Radiation Protection and Nuclear Safety (IRSN), Fontenay-Aux-Roses, France.

Virginie Monceau (V)

Laboratory of Radiotoxicology and Radiobiology, Institute for Radiation Protection and Nuclear Safety (IRSN), Fontenay-Aux-Roses, France.

Jean Ferrières (J)

Department of Cardiology and INSERM UMR 1295, Rangueil University Hospital, Toulouse, France.

Juliette Thariat (J)

Department of Radiotherapy, Centre de Lutte Contre le Cancer A. Baclesse, University of Caen Normandie, Caen, France.

Serge Boveda (S)

Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.

Youlia Kirova (Y)

Department of Radiation Oncology, Institut Curie, Paris, France.

Pierre Loap (P)

Department of Radiation Oncology, Institut Curie, Paris, France.

Johannes A Langendijk (JA)

Department of Radiation Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, Netherlands.

Anne Crijns (A)

Department of Radiation Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, Netherlands.

Sophie Jacob (S)

Laboratory of Epidemiology, Institute for Radiation Protection and Nuclear Safety (IRSN), Fontenay-Aux-Roses, France.

Classifications MeSH